An alarming rise in the prevalence of chronic ailments including cardiovascular and neurovascular diseases, orthopedic disorders, general surgery, and wound management has put forth the need for platelet rich plasma treatment. In addition, a significant boost in demand for aesthetic procedures is further propelling the worldwide demand for platelet-rich plasma treatment. With the...

The global recombinant DNA technology market is driven by increased applications in the treatment of fatal human diseases such as infectious diseases. The advancement in recombinant technology has led to the development of gene therapy, long-acting therapeutic proteins for drugs, and cutting-edge molecular medicine. The ongoing technological development coupled with these therapies'...